Ibritumomab and malignant neoplasm progression Patient Reports March 21, 2010

Ibritumomab Side Effects Report #5366252-9
Ibritumomab side effect was reported by a Physician from UNITED STATES on June 19, 2007. Female patient, weighting 126.0 lb, was treated with Ibritumomab. After drug was administered, patient experienced the following side effects: breast cancer female, feeding disorder, gastric ulcer, impaired healing, malignant neoplasm progression, nausea , pain . Ibritumomab dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.